Literature DB >> 11740710

Staphylococcus aureus infections and antibiotic resistance in older adults.

Suzanne F Bradley1.   

Abstract

The prevalence of infection with Staphylococcus aureus among older adults is unknown, but clinical syndromes caused by this organism are common. Bacteremia, pneumonia, endocarditis, and bone and joint infections are encountered with relative frequency in this population, and the clinical presentation may be atypical. Underlying disease and functional debility, rather than age itself, predispose the older adult to staphylococcal carriage and infection. Infections with methicillin-resistant strains of S. aureus are acquired primarily in hospital, rather than in nursing homes or in the community. Lack of clinical suspicion for S. aureus infection and delays in appropriate therapy can be fatal. Staphylococcal infection should be considered for an older adult with risk factors for staphylococcal carriage, comorbid illness, debility, and history of recent hospitalization or nursing home stay. Choices regarding empirical therapy should be made on the basis of knowledge of local antibiotic susceptibility patterns.

Entities:  

Mesh:

Year:  2001        PMID: 11740710     DOI: 10.1086/338150

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  13 in total

1.  Profile of methicillin-resistant Staphylococcus aureus among nursing home residents in Hawai'i.

Authors:  Fenfang Li; Pamela Arnsberger; F DeWolfe Miller
Journal:  Hawaii Med J       Date:  2010-05

2.  Healthcare-associated pathogens and nursing home policies and practices: results from a national survey.

Authors:  Zhiqiu Ye; Dana B Mukamel; Susan S Huang; Yue Li; Helena Temkin-Greener
Journal:  Infect Control Hosp Epidemiol       Date:  2015-03-23       Impact factor: 3.254

3.  Risk of transmission of imipenem-resistantPseudomonas aeruginosa through use of mobile bathing service.

Authors:  Naomi Sakurai-Komada; Masako Hirano; Ikumi Nagata; Yumi Ejima; Michiko Nakamura; Kazuko A Koike
Journal:  Environ Health Prev Med       Date:  2006-01       Impact factor: 3.674

Review 4.  New developments in antibacterial choice for lower respiratory tract infections in elderly patients.

Authors:  Anna Maria Ferrara; Anna Maria Fietta
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

5.  Molecular epidemiology of Staphylococcus aureus colonization in 2 long-term care facilities.

Authors:  Lona Mody; Erica Flannery; Andrew Bielaczyc; Suzanne F Bradley
Journal:  Infect Control Hosp Epidemiol       Date:  2006-02-08       Impact factor: 3.254

6.  Role of Interleukin-12 in Protection against Pulmonary Infection with Methicillin-Resistant Staphylococcus aureus.

Authors:  Quang-Tam Nguyen; Yoichi Furuya; Sean Roberts; Dennis W Metzger
Journal:  Antimicrob Agents Chemother       Date:  2015-07-27       Impact factor: 5.191

7.  Tet38 Efflux Pump Affects Staphylococcus aureus Internalization by Epithelial Cells through Interaction with CD36 and Contributes to Bacterial Escape from Acidic and Nonacidic Phagolysosomes.

Authors:  Q C Truong-Bolduc; N S Khan; J M Vyas; D C Hooper
Journal:  Infect Immun       Date:  2017-01-26       Impact factor: 3.441

8.  Mupirocin-based decolonization of Staphylococcus aureus carriers in residents of 2 long-term care facilities: a randomized, double-blind, placebo-controlled trial.

Authors:  Lona Mody; Carol A Kauffman; Shelly A McNeil; Andrzej T Galecki; Suzanne F Bradley
Journal:  Clin Infect Dis       Date:  2003-11-06       Impact factor: 9.079

9.  A 25-year trace of methicillin-resistant Staphylococcus aureus dissemination in a geriatric hospital in Japan.

Authors:  Fuminori Sakai; Hideaki Hanaki; Kazunari Barada; Yuriko Hirao; Takashi Inamatsu; Taiji Nakae; Keisuke Sunakawa
Journal:  Int J Gen Med       Date:  2010-12-09

10.  Haematogenous Staphylococcus aureus meningitis. A 10-year nationwide study of 96 consecutive cases.

Authors:  Michael Pedersen; Thomas L Benfield; Peter Skinhoej; Allan G Jensen
Journal:  BMC Infect Dis       Date:  2006-03-16       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.